📰 Genentech News
Page 105 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
September 5, 2023
(RTTNews) - Shares of Nykode Therapeutics ASA were gaining around 4 percent in the morning trading in Norway after the company announced that the ...
September 5, 2023
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023 Lausanne, Switzerland, September 05, 2023 – AC Immune SA (NASDAQ:ACIU), a clinical-stage biopharmaceutical company
September 5, 2023
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on...
September 5, 2023
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20. OSLO, Norway, Sept. 05, 2023 (GLOBE NEWSWIRE)
September 5, 2023
FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on September 20.
September 5, 2023
The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and patients in technology design and...
September 5, 2023
The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals...
September 5, 2023
The report shows digital health technologies demonstrate value, yet integrating them into care systems remains challenging. Involving healthcare professionals and...
September 5, 2023
In last year’s scramble to include government price controls on prescription drugs in President Biden’s Inflation Reduction Act, Democrats were willing to say almost anything. They reassured us that their scheme applied only to Medicare and would phase in slowly, with ample opportunity for stock-taking.
September 4, 2023
Imugene Ltd (ASX:IMU, OTC:IUGNF) has cleared the first cohort of patients of the intratumoral (IT) arm of its VAXINIA metastatic advanced solid tumours...